NTRK2 and malignant colon neoplasm: A basic research study showed that TrkB/C activation leads to subsequent activation of MEK/ERK signaling pathway, promoting the activation of ADAM8 mediated by HOXC6 and inducing the metastasis of colon cancer cells that are resistant to chemotherapy.